First Manhattan’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,500
| Closed | -$13.1K | – | 1458 |
|
|
2023
Q3 | $13.1K | Hold |
3,500
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q2 | $14.9K | Hold |
3,500
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q1 | $23.9K | Hold |
3,500
| – | – | ﹤0.01% | 1053 |
|
|
2022
Q4 | $27.7K | Hold |
3,500
| – | – | ﹤0.01% | 1040 |
|
|
2022
Q3 | $33K | Hold |
3,500
| – | – | ﹤0.01% | 997 |
|
|
2022
Q2 | $25K | Hold |
3,500
| – | – | ﹤0.01% | 1075 |
|
|
2022
Q1 | $45K | Hold |
3,500
| – | – | ﹤0.01% | 1022 |
|
|
2021
Q4 | $55K | Hold |
3,500
| – | – | ﹤0.01% | 975 |
|
|
2021
Q3 | $56K | Hold |
3,500
| – | – | ﹤0.01% | 965 |
|
|
2021
Q2 | $48K | Hold |
3,500
| – | – | ﹤0.01% | 991 |
|
|
2021
Q1 | $51K | Hold |
3,500
| – | – | ﹤0.01% | 957 |
|
|
2020
Q4 | $60K | Hold |
3,500
| – | – | ﹤0.01% | 873 |
|
|
2020
Q3 | $64K | Hold |
3,500
| – | – | ﹤0.01% | 848 |
|
|
2020
Q2 | $62K | Hold |
3,500
| – | – | ﹤0.01% | 838 |
|
|
2020
Q1 | $56K | Hold |
3,500
| – | – | ﹤0.01% | 826 |
|
|
2019
Q4 | $63K | Hold |
3,500
| – | – | ﹤0.01% | 868 |
|
|
2019
Q3 | $70K | Buy |
+3,500
| New | +$70K | ﹤0.01% | 849 |
|
|
2015
Q4 | – | Sell |
-5,000
| Closed | -$100K | – | 1421 |
|
|
2015
Q3 | $100K | Buy |
+5,000
| New | +$100K | ﹤0.01% | 806 |
|